CoChat

The Role of Fluconazole in the Treatment of Candida Endocarditis: A Meta-Analysis

Smego, Raymond A., Ahmad, Hassan · 2011 · Medicine

The DOI matches its Crossref record; 90 of the 94 references it cites were found in a registry or an index.

Abstract

The treatment of Candida infective endocarditis generally involves infected valve removal accompanied by antifungal therapy with amphotericin B or a lipid-based derivative, with or without flucytosine. While often used as chronic suppressive therapy in these patients, the precise role for fluconazole has not been established. We conducted a meta-analysis of 64 literature cases of Candida endocarditis whose management did not include valve replacement but who received fluconazole, alone or concurrently or in sequence with 1 or more other antifungal drugs.Forty-nine (77%) patients were cured (n = 44) or improved (n = 5), 4 relapsed (6%), and 11 failed (10 of whom died) (17%). Among 19 patients for whom fluconazole was administered as the sole antifungal therapy, 11 (58%) were cured or improved. In contrast, among 45 patients who received 1 or more other antifungal agents in addition to fluconazole, 38 (84%) were cured or improved (p = 0.02). Eighteen of 21 (86%) patients with native valve infection were cured or improved compared with 13 of 19 (68%) patients with prosthetic valve endocarditis (p = 0.13). The mean duration of successful fluconazole regimens was 134 days. Twenty of 21 (95%) patients who received fluconazole as chronic suppressive therapy for ≥6 months were cured. Prognosis was independent of Candida species or patient age. Among 23 historical controls managed with fluconazole-containing antifungal therapy plus valvular surgery, survival was 91%.In conclusion, flu…

Overview

Integrity signals

Registry

Crossref · 10.1097/md.0b013e3182259d38

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 90 references

Research works printed but not linked: 2

  1. Pinar, 2010, Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis., Enferm Infecc Microbiol Clin, 28, 66
  2. Yap, 1999, Successful treatment of Candida albicans endocarditits in a child with leukemia: a case report and review of the literature., Singapore Med J, 40, 533

Cited by

See all 56

Metadata

Authors
Smego, R. A., & Ahmad, H.
Affiliations
Geisinger College of Health Sciences (US)
Venue
Medicine
Published
2011-07
Volume
90
Issue
4
Pages
237-249
ISSN
0025-7974 (ISSN-L)
OpenAlex
W2334211593
Cited by
56
References
94
Citations by year
2026: 2 · 2025: 7 · 2024: 4 · 2023: 7 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 6 · 2013: 1 · 2012: 3
FWCI
0.38
Type
journal article
Language
en
Open access
closed
Locations
  • Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords
Candida endocarditis, fluconazole, antifungal therapy, combination antifungal therapy, valve replacement, prosthetic valve endocarditis, native valve endocarditis, amphotericin B, 5-fluorocytosine, treatment outcomes
MeSH terms
Adult, Aged, Aged, 80 and over, Antifungal Agents, Candida albicans, Candidiasis, Dose-Response Relationship, Drug, Drug Administration Schedule, Endocarditis, Female, Humans, Male, Middle Aged, Prognosis, Recurrence, Severity of Illness Index, United States, Fluconazole, Survival Rate, Treatment Outcome, Risk Assessment, Candidemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Fluconazole in the Treatment of Candida Endocarditis: A Meta-Analysis. https://app.cochat.ai/papers/10.1097/md.0b013e3182259d38
The paper
Smego, R. A., & Ahmad, H. (2011). The Role of Fluconazole in the Treatment of Candida Endocarditis: A Meta-Analysis. Medicine. https://doi.org/10.1097/md.0b013e3182259d38

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.